// App-Quantinova.ai

289 : Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: An international cohort study.

Researchers

Presenter

  • Jessica Howell

Principal Investigators

  • Amit Samani

  • Binish Mannan

  • Saur Hajiev

  • Leila Motedayan Aval

  • Rebecca Abdelmalak

  • Vincent C. Tam

  • Dominik Bettinger

  • Robert Thimme

  • Tamar Hamosh Taddei

  • David Edward Kaplan

  • Max Seidensticker

  • Rohini Sharma

Medical Centers

  • University of Melbourne, Melbourne, Australia

  • Guy's and St Thomas' NHS Foundation Trust and Kings College Medical School, London, United Kingdom

  • University of Calgary Tom Baker Cancer Centre, Calgary, AB, Canada

  • Berta Ottenstein Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany

  • University of Freiburg, Freiburg, Germany

  • Yale School of Medicine, Yale University, New Haven, CT

  • Michael J Crescenz VA Medical Center, Philadelphia, PA

  • Klinikum Grohadern, Radiologie, Munich, Germany

Locations

  • Australia

  • United Kingdom

  • Canada

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Liver cancer

  • Nonalcoholic fatty liver disease

Biomarkers

  • N/A

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved